Next year’s codeine behaviour forecast

New figures show many will still see pharmacy as their first port of call for pain relief after codeine is upscheduled New research from Sanofi Consumer Healthcare investigated the likely impact of the upcoming regulatory changes, following the TGA’s decision to upschedule low-dose codeine to prescription only. A significant number— 45%—will still head straight to